SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Directorate Change

1 Aug 2013 07:00

RNS Number : 6609K
Rentokil Initial PLC
01 August 2013
 



 

 

 

1 August 2013

 

Appointment of Chief Executive Officer

 

Rentokil Initial plc (LSE: RTO), the international support services company, today announces that Alan Brown, Chief Executive Officer, has decided to step down from the Company. After a thorough succession planning process, including an external search, Andy Ransom, currently Regional Managing Director and Executive Director, will succeed Alan as CEO on 1st October 2013. Alan Brown will step down from the Board on that date. He will remain available to support the business to ensure a smooth transition through to the end of January 2014.

 

Alan Brown joined Rentokil Initial in April 2008 as Chief Executive. Under his leadership, Rentokil Initial has undergone significant transformation to focus on its core international operations of pest control, hygiene, workwear and plants and has built substantial capability across all functions. It has expanded its geographical footprint significantly in North America, the world's largest pest control market and established a presence in Brazil, China, Turkey, India and the Middle East. The Company disposed of its City Link parcels business in April 2013.

 

Andy Ransom joined Rentokil Initial in 2008 from ICI. He is Regional Managing Director of the West Region which includes all operations in the Americas, Middle East, Africa and parts of Europe. He also leads on M&A and Legal.

 

John McAdam, Chairman of Rentokil Initial plc, said: "I'd like to thank Alan for his major contribution to the Company. In 2008 we faced huge challenges. Alan has navigated us through many of them and today we are in a much stronger position to continue our international growth strategy.

 

"Andy is a natural successor and his experience in running our operations in the Americas, Africa, Asia Pacific and parts of Europe gives the Board every confidence in his ability to build on Alan's achievements. He has a deep understanding of the Company, its global markets and growth opportunities. On behalf of the Board I wish him well."

 

Alan Brown said: "I thank the Board, our shareholders and above all my colleagues for the great support they have offered me over the last five years. I am delighted that the Board has chosen Andy as my successor and I wish him every good fortune."

 

Rentokil Initial plc's interim results will be published on 14th August 2013 as previously announced. The results are anticipated to be in line with expectations.

 

The contractual terms can be found overleaf.

 

 

ENDS

 

 

Note to Editors

 

Andy M Ransom (50)

Andy Ransom graduated from the University of Southampton. He qualified as a solicitor in 1987 and joined ICI Plc in the same year, specialising as a senior mergers and acquisitions lawyer in the corporate centre.

He was seconded as Vice President to ICI Explosives in Toronto, Canada, in 1996 and in 1998 became General Counsel for ICI in the Americas, based in New Jersey, USA.

In 2000 he was appointed Group Vice President Mergers and Acquisitions and was appointed as a Member of the Executive Management Team in July 2005 where he was General Counsel, Executive Vice President Mergers and Acquisitions and Company Secretary.

In 2007 he took on executive responsibility for ICI's Regional and Industrial Division, primarily in Pakistan and India. 

In 2008 he joined Rentokil Initial as an Executive Director, over time taking responsibility for the Company's Pest Control Division and latterly West Region.

 

There are no details to disclose under paragraph 9.6.13R of the Listing Rules in relation to Mr Ransom.

 

Andy Ransom appointment terms with effect from 1 October 2013

 

Salary

 

Bonus

 

 

LTIP (i)

 

Pension

 

Car Allowance

 

Benefits

 

 

 

 

Holidays

 

Notice

£700,000

 

100% max

50% "on target"

 

120% target award (200% maximum)

 

25% with NI adjustment

 

£18,000 pa

 

Private medical insurance

Income Protection

Life Cover

D & O Cover

 

25 days pa

 

12 months/12 months employer/employee

 

 

(i) Supplementary LTIP award in 2013 - under the standard LTIP arrangements to be made at the time of appointment to the value of £390,000 which represents the difference between current salary and new salary.

 

Alan Brown contract details

 

·; Retiring from the Company with period of notice to expire on 31 January 2014

·; Salary and other contractual benefits will be provided until the last day of employment on 31 January 2014

·; Bonus entitlement for 2013 service only

·; Outstanding LTIP awards will be pro-rated and will vest only to the extent performance conditions are met

·; All post-termination contractual restrictions will remain in force

 

 

 

About Rentokil Initial plc

 

Rentokil Initial is one of the largest business services companies in the world, operating in all the major economies of Europe, North America, Asia Pacific and Africa. It employs some 60,000 colleagues providing a range of services in over 60 countries.

 

www.rentokil-initial.com

 

 

 

Enquiries:

 

Investors / Analysts enquiries:

Katharine Rycroft, Head of Investor Relations Rentokil Initial plc 01293 858 166

 

Media enquiries:

Malcolm Padley, Corporate Communications Rentokil Initial plc 07788 978 199

Justine McIlroy / Catriona McDermott / Oliver Hughes Brunswick Group 020 7404 5959

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAWGURUMUPWGMG
Date   Source Headline
28th Jul 20253:00 pmRNSHolding(s) in Company
10th Jul 202511:00 amRNSHolding(s) in Company
1st Jul 202510:25 amRNSTotal Voting Rights
10th Jun 202510:05 amRNSAdditional Listing
3rd Jun 20254:00 pmRNSDirector/PDMR Shareholding
28th May 20257:00 amRNSSale of France Workwear
19th May 20252:30 pmRNSDirector/PDMR Shareholding
7th May 20254:15 pmRNSResult of AGM
7th May 20257:01 amRNSDirectorate Change: Appointment of NEDs
7th May 20257:00 amRNSDirectorate Change: Chief Executive to retire
28th Apr 20252:30 pmRNSIssue of Debt
17th Apr 20252:20 pmRNSHolding(s) in Company
17th Apr 20257:00 amRNSQ1 Trading Update
9th Apr 202510:25 amRNSHolding(s) in Company
1st Apr 20252:15 pmRNSNotice of Q1 Trading Update and Management Call
1st Apr 202510:25 amRNSBlock listing Interim Review
27th Mar 202510:25 amRNSDirector/PDMR Shareholding
26th Mar 202510:30 amRNSAnnual Financial Report
14th Mar 202510:00 amRNSDirector/PDMR Shareholding
6th Mar 20257:00 amRNSFinal Results
28th Jan 20257:00 amRNSTrading Update (unaudited)
14th Jan 202511:15 amRNSHolding(s) in Company
13th Jan 202511:15 amRNSHolding(s) in Company
13th Dec 20249:30 amRNSDirector/PDMR Shareholding
25th Nov 20247:00 amRNSDirectorate Change
12th Nov 202410:30 amRNSHolding(s) in Company
8th Nov 202410:30 amRNSHolding(s) in Company
17th Oct 20247:00 amRNSQ3 Trading Update
1st Oct 20242:00 pmRNSBlock listing Interim Review
25th Sep 20247:00 amRNSAppointment of Non-Executive Director
19th Sep 202410:30 amRNSDirector/PDMR Shareholding
11th Sep 20247:00 amRNSTrading Update
10th Sep 202410:30 amRNSHolding(s) in Company
5th Sep 202411:08 amRNSHolding(s) in Company
25th Jul 20247:00 amRNS2024 Interim Results
10th Jul 20244:35 pmRNSHolding(s) in Company
26th Jun 20245:12 pmRNSDirector/PDMR Shareholding
26th Jun 202411:08 amRNSHolding(s) in Company
17th May 20243:30 pmRNSDirector/PDMR Shareholding
8th May 20242:00 pmRNSResult of AGM
29th Apr 20243:00 pmRNSHolding(s) in Company
23rd Apr 20249:30 amRNSHolding(s) in Company
18th Apr 20247:00 amRNSQ1 Trading Update
2nd Apr 20241:28 pmRNSBlock listing Interim Review
2nd Apr 202412:17 pmRNSTotal Voting Rights
27th Mar 202410:23 amRNSAnnual Financial Report
19th Mar 20242:05 pmRNSAdditional Listing
14th Mar 202410:19 amRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSFinal Results
1st Dec 20237:00 amRNSNorth American Management Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.